Andrew John Phillips

Insider Reports History

Location
C/O Cormorant Asset Management, Llp, 200 Clarendon Street, Fl 52, Boston, MA
Signature
/s/ Matthias Bodenstedt, Attorney-in-fact for Andrew John Phillips
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew John Phillips:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. Director Stock Option (right to buy) 20.5K Feb 6, 2025 Direct
OnKure Therapeutics, Inc. Director Stock Option (right to buy) 7.65K May 28, 2025 Direct
MoonLake Immunotherapeutics Director Option to Buy 6.68K Jun 5, 2025 Direct

Insider Reports Filed by Andrew John Phillips

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MLTX MoonLake Immunotherapeutics Jun 5, 2025 1 $0 4 Jun 9, 2025 Director
OKUR OnKure Therapeutics, Inc. May 28, 2025 1 $0 4 May 30, 2025 Director
ELVN Enliven Therapeutics, Inc. Feb 6, 2025 1 $0 4 Feb 10, 2025 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 1 $0 4 Oct 8, 2024 Director
OKUR OnKure Therapeutics, Inc. Oct 4, 2024 0 $0 3 Oct 8, 2024 Director
MLTX MoonLake Immunotherapeutics Jun 6, 2024 1 $0 4 Jun 7, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4/A Feb 20, 2024 Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 Director
MLTX MoonLake Immunotherapeutics Jun 8, 2023 1 $0 4 Jun 12, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 1 $0 4 Apr 6, 2023 Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 Director
MLTX MoonLake Immunotherapeutics Apr 6, 2022 1 $0 4 May 5, 2022 Director
MLTX MoonLake Immunotherapeutics Apr 5, 2022 0 $0 3 Apr 15, 2022 Director